Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study. - Cubała WJ; Berrio A; Chi-Burris K; Alva G; Chrones L; Pathak S (Journal of Alzheimer's disease : JAD, 2025)